Mechanisms of Action of Nutritionally Rich Hibiscus sabdariffa's Therapeutic Uses in Major Common Chronic Diseases: A Literature Review
- PMID: 33507846
- DOI: 10.1080/07315724.2020.1848662
Mechanisms of Action of Nutritionally Rich Hibiscus sabdariffa's Therapeutic Uses in Major Common Chronic Diseases: A Literature Review
Abstract
Hibiscus sabdariffa, this beverage has been used for millennia as both a delicious cultural beverage and an ancient medicinal therapy. In recent years, many studies have investigated the uses and mechanisms of action of Hibiscus sabdariffa to treat common chronic diseases. In this literature review, we place the spotlight on Hibiscus sabdariffa's medical effect on common chronic diseases, the flower commonly used to make hibiscus tea. The databases PubMed, MEDLINE, Clinical Key, and CINAHL were searched for studies related to Hibiscus sabdariffa's compounds, antioxidative and anti-inflammatory features, mechanism of action on common chronic diseases including hypertension, hyperlipidemia, obesity, diabetes, and Alzheimer's disease. Hibiscus sabdariffa antihypertensive potentials originate from the vasodilator activity, diuretic efficacy, functionality as an ACE inhibitor, adipocyte differentiation inhibitor, heart rate reduction ability, and anti-inflammatory mechanistic. The antihyperlipidemic effect is dose-dependent and stems from the antioxidative effect and the activation of AMPK through phosphorylation and the inhibition of regulatory adipogenic transcription factors PPAR-γ, C/EBP-α, and SREBP-1c, which altogether results in lipid-lowering effect. As an antihyperglycemic, Hibiscus sabdariffa serves as anti-insulin resistance by inhibition of the phosphorylation of IRS-1 beside a similar effect to gliptins. Finally, Hibiscus sabdariffa was proven to protect against neuroinflammation in microglial cell culture exposed to LPS by decreasing IL-1, IL-6, TNF-α expression, and the protective effect against glucotoxicity, improve memory function by inhibiting the formation of hyperphosphorylated tau proteins in the mouse brain. Regular consumption of hibiscus tea or extract is beneficial for a reduction in chronic disease risk and diagnosis.Key teaching pointsHibiscus sabdariffa, or hibiscus, has been used for millennia as both a delicious cultural beverage and an ancient medicinal therapy. Recent studies have investigated the uses of Hibiscus sabdariffa to treat common chronic diseases.Its antihypertensive potential originates from the vasodilator activity, diuretic efficacy, functionality as an ACE inhibitor, adipocyte differentiation inhibitor, heart rate reduction ability, and anti-inflammatory mechanistics.The antihyperlipidemic effect is dose-dependent and stems from the antioxidative effect and the activation of AMPK through phosphorylation and also the inhibition of regulatory adipogenic transcription factors PPAR-γ, C/EBP-α and SREBP-1c which all together results in lipid-lowering effect.As an antihyperglycemic, Hibiscus sabdariffa serves as anti-insulin resistance by inhibition of the phosphorylation of IRS-1 beside the similar effect to gliptins.Hibiscus sabdariffa was proven to protect against neuroinflammation in microglial cell culture exposed to LPS by decreasing IL-1, IL-6, TNF-α expression, and the protective effect against glucotoxicity, improve memory function by inhibiting the formation of hyperphosphorylated tau proteins in the mouse brain.
Keywords: Alzheimer's disease; Hibiscus sabdariffa; Phytomedicine; antioxidant; chronic diseases; herbal medicine.
Similar articles
-
Hibiscus sabdariffa L. polyphenolic-rich extract promotes muscle glucose uptake and inhibits intestinal glucose absorption with concomitant amelioration of Fe2+ -induced hepatic oxidative injury.J Food Biochem. 2022 Dec;46(12):e14399. doi: 10.1111/jfbc.14399. Epub 2022 Oct 18. J Food Biochem. 2022. PMID: 36259155
-
Triterpenoids from Hibiscus sabdariffa L. with PPARδ/γ Dual Agonist Action: In Vivo, In Vitro and In Silico Studies.Planta Med. 2019 Mar;85(5):412-423. doi: 10.1055/a-0824-1316. Epub 2019 Jan 16. Planta Med. 2019. PMID: 30650453
-
AMPK activating and anti adipogenic potential of Hibiscus rosa sinensis flower in 3T3-L1 cells.J Ethnopharmacol. 2019 Apr 6;233:123-130. doi: 10.1016/j.jep.2018.12.039. Epub 2018 Dec 26. J Ethnopharmacol. 2019. PMID: 30593890
-
Hibiscus sabdariffa (Roselle) calyx: a systematic and meta-analytic review of memory-enhancing, anti-neuroinflammatory and antioxidative activities.Inflammopharmacology. 2023 Feb;31(1):231-240. doi: 10.1007/s10787-022-01101-z. Epub 2022 Nov 27. Inflammopharmacology. 2023. PMID: 36436183 Review.
-
A review on phytochemistry and therapeutic uses of Hibiscus sabdariffa L.Biomed Pharmacother. 2018 Jun;102:575-586. doi: 10.1016/j.biopha.2018.03.023. Epub 2018 Apr 5. Biomed Pharmacother. 2018. PMID: 29597091 Review.
Cited by
-
The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins.Int J Mol Sci. 2023 May 22;24(10):9085. doi: 10.3390/ijms24109085. Int J Mol Sci. 2023. PMID: 37240430 Free PMC article. Review.
-
Targets and Effects of Common Biocompounds of Hibiscus sabdariffa (Delphinidin-3-Sambubiosid, Quercetin, and Hibiscus Acid) in Different Pathways of Human Cells According to a Bioinformatic Assay.Nutrients. 2024 Feb 19;16(4):566. doi: 10.3390/nu16040566. Nutrients. 2024. PMID: 38398890 Free PMC article.
-
Decomposing differences in the chronic disease condition between rural and urban older adults in China: a cross-sectional analysis.Front Public Health. 2024 Jan 5;11:1298657. doi: 10.3389/fpubh.2023.1298657. eCollection 2023. Front Public Health. 2024. PMID: 38249386 Free PMC article.
-
Hibiscus sabdariffa in Diabetes Prevention and Treatment-Does It Work? An Evidence-Based Review.Foods. 2022 Jul 19;11(14):2134. doi: 10.3390/foods11142134. Foods. 2022. PMID: 35885378 Free PMC article. Review.
-
The Dipeptide Gly-Pro (GP), Derived from Hibiscus sabdariffa, Exhibits Potent Antifibrotic Effects by Regulating the TGF-β1-ATF4-Serine/Glycine Biosynthesis Pathway.Int J Mol Sci. 2023 Sep 3;24(17):13616. doi: 10.3390/ijms241713616. Int J Mol Sci. 2023. PMID: 37686422 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous